| Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ... MedRxiv, 2020.06. 22.20137273, 2020 | 9482 | 2020 |
| Dexamethasone in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 384 (8), 693-704, 2021 | 2838 | 2021 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1473 | 2020 |
| Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) MR Cowie, M Komajda, T Murray-Thomas, J Underwood, B Ticho European Heart Journal 27 (10), 1216-1222, 2006 | 482 | 2006 |
| Persistent viral shedding of SARS‐CoV‐2 in faeces–a rapid review S Gupta, J Parker, S Smits, J Underwood, S Dolwani Colorectal Disease 22 (6), 611-620, 2020 | 231 | 2020 |
| Increased brain-predicted aging in treated HIV disease JH Cole, J Underwood, MWA Caan, D De Francesco, RA Van Zoest, ... Neurology 88 (14), 1349-1357, 2017 | 225 | 2017 |
| Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls A Yilmaz, K Blennow, L Hagberg, S Nilsson, RW Price, J Schouten, ... Expert review of molecular diagnostics 17 (8), 761-770, 2017 | 151 | 2017 |
| Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? J Underwood, KR Robertson, A Winston Aids 29 (3), 253-261, 2015 | 149 | 2015 |
| No evidence for accelerated aging-related brain pathology in treated human immunodeficiency virus: longitudinal neuroimaging results from the comorbidity in relation to AIDS … JH Cole, MWA Caan, J Underwood, D De Francesco, RA van Zoest, ... Clinical Infectious Diseases 66 (12), 1899-1909, 2018 | 95* | 2018 |
| Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial TSC Hinks, L Cureton, R Knight, A Wang, JL Cane, VS Barber, J Black, ... The Lancet Respiratory Medicine 9 (10), 1130-1140, 2021 | 93 | 2021 |
| Defining cognitive impairment in people-living-with-HIV: the POPPY study D De Francesco, J Underwood, FA Post, JH Vera, I Williams, M Boffito, ... BMC infectious diseases 16, 1-9, 2016 | 83 | 2016 |
| Gray and white matter abnormalities in treated human immunodeficiency virus disease and their relationship to cognitive function J Underwood, JH Cole, M Caan, D De Francesco, R Leech, RA Van Zoest, ... Clinical Infectious Diseases 65 (3), 422-432, 2017 | 82 | 2017 |
| Treatment of chronic or relapsing COVID-19 in immunodeficiency LAK Brown, E Moran, A Goodman, H Baxendale, W Bermingham, ... Journal of Allergy and Clinical Immunology 149 (2), 557-561. e1, 2022 | 69 | 2022 |
| Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis J Alagaratnam, S von Widekind, D De Francesco, J Underwood, P Edison, ... BMJ neurology open 3 (1), 2021 | 64 | 2021 |
| Patterns of co-occurring comorbidities in people living with HIV D De Francesco, SO Verboeket, J Underwood, E Bagkeris, FW Wit, ... Open forum infectious diseases 5 (11), ofy272, 2018 | 53 | 2018 |
| Guidelines for evaluation and management of cognitive disorders in HIV-positive individuals J Underwood, A Winston Current Hiv/aids Reports 13 (5), 235-240, 2016 | 53 | 2016 |
| Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy J Underwood, M Marks, S Collins, S Logan, G Pollara Journal of Antimicrobial Chemotherapy 74 (3), 787-790, 2019 | 52 | 2019 |
| Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers RA Van Zoest, J Underwood, D De Francesco, CA Sabin, JH Cole, FW Wit, ... The Journal of Infectious Diseases 217 (1), 69-81, 2018 | 49 | 2018 |
| Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a … A Evans, C Qi, JO Adebayo, J Underwood, J Coulson, R Bailey, R Lyons, ... Journal of Infection 86 (4), 352-360, 2023 | 40 | 2023 |
| Cognitive impairment in people living with HIV: consensus recommendations for a new approach S Nightingale, B Ances, P Cinque, A Dravid, AJ Dreyer, M Gisslén, ... Nature Reviews Neurology 19 (7), 424-433, 2023 | 38 | 2023 |
